NCI Cancer Bulletin for January 24, 2012

January 24, 2012 • Volume 9 / Number 2

Read the NCI Cancer Bulletin

The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.

News

Read This Issue


  • Featured Article: Genetic Abnormality Predicts Treatment Benefit for Patients with Rare
    Brain Tumor »
  • Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers »
  • Experimental Drug Improves Survival in Previously Treated Metastatic Colorectal Cancer »
  • Differences in Estrogen Metabolism May Influence Breast Cancer Risk »
  • Epigenetic Study Suggests Possible Treatment for Retinoblastoma »
  • Also in the Journals: Before Breast Cancer Surgery, Two Anti-HER2 Drugs May Be
    Better than One
    »

 

Commentary

Read This Issue


  • A Conversation with the NCI Women Scientist Advisors »

In Depth

Read This Issue


  • More than a Game: Super Bowl Initiative Helps Scientists Study the "Normal" Breast »
  • Staying Alive: New Technique Grows Normal and Cancer Cells Rapidly »
  • Targeted Therapies Offer Treatment Options for Advanced Kidney Cancer »
  • Featured Clinical Trial: First-in-Humans Study of New Immunotherapy Agent »

Updates

Read This Issue


  • FDA Update »
  • Notes »

Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.   

 

No comments:

Post a Comment